Filing Details
- Accession Number:
- 0001127602-17-006904
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-17 16:10:48
- Reporting Period:
- 2017-02-16
- Filing Date:
- 2017-02-17
- Accepted Time:
- 2017-02-17 16:10:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
64803 | Cvs Health Corp | CVS | Retail-Drug Stores And Proprietary Stores (5912) | 050494040 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1410515 | C Jonathan Roberts | One Cvs Drive Woonsocket RI 02895- | Evp & President, Cvs Caremark | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-02-16 | 61,196 | $36.23 | 89,955 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-02-16 | 61,196 | $80.00 | 28,759 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2017-02-16 | 61,196 | $0.00 | 61,196 | $36.23 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-04-01 | 2017-04-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock (Pep) | 11,703 | Direct | |
Common Stock (Restricted) | 60,753 | Direct | |
Esop Common Stock | 5,320 | Indirect | By ESOP |
Stock Unit | 113,725 | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Phantom Stock Credits | $1.00 | 1,417 | 1,417 | Direct | ||
Common Stock | Stock Option | $34.96 | 2012-04-01 | 2018-04-01 | 85,743 | 85,743 | Direct |
Common Stock | Stock Option | $45.07 | 2013-04-02 | 2019-04-02 | 77,639 | 77,639 | Direct |
Common Stock | Stock Option | $54.53 | 2014-04-01 | 2020-04-01 | 68,844 | 68,844 | Direct |
Common Stock | Stock Option | $74.29 | 2015-04-01 | 2021-04-01 | 73,433 | 73,433 | Direct |
Common Stock | Stock Option | $45.93 | 2015-09-04 | 2022-09-04 | 108,870 | 108,870 | Direct |
Common Stock | Stock Option | $102.26 | 2016-04-01 | 2022-04-01 | 68,482 | 68,482 | Direct |
Common Stock | Stock Option | $104.82 | 2017-04-01 | 2023-04-01 | 161,318 | 161,318 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
1,417 | 1,417 | Direct | |
2018-04-01 | 85,743 | 85,743 | Direct |
2019-04-02 | 77,639 | 77,639 | Direct |
2020-04-01 | 68,844 | 68,844 | Direct |
2021-04-01 | 73,433 | 73,433 | Direct |
2022-09-04 | 108,870 | 108,870 | Direct |
2022-04-01 | 68,482 | 68,482 | Direct |
2023-04-01 | 161,318 | 161,318 | Direct |
Footnotes
- All sales were effected pursuant to a Rule 10b5-1 plan.
- Option became exercisable in three annual installments, commencing 4/1/2011.
- Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- Option became exercisable in four equal annual installments, commencing 4/1/2012.
- Option became exercisable in four equal annual installments, commencing 4/2/2013.
- Option became exercisable in four equal annual installments, commencing 4/1/2014.
- Option became exercisable in four equal annual installments, commencing 4/1/2015.
- Option became exercisable in three equal annual installments, commencing 9/4/2015.
- Option became exercisable in four equal annual installments, commencing 4/1/2016.
- Option becomes exercisable in four equal annual installments, commencing 4/1/2017.